
    
      Visiobiane study is a randomized trial of 30 participants designed to assess the effects of
      oral supplementation of macular xanthophylls (lutein and zeaxanthin) and omega-3 LCPUFAs for
      the eyes protection. The study will enroll healthy participants aged 45 to 55 years. 15
      subjects will be assigned in placebo group and 15 in experimetal group (Visiobiane anti-age).
      They will be supplemented for 24 weeks
    
  